Clayface hits theaters this Friday — not with a bang, but with a squelch. The R-rated body horror spin on the DC villain lands in cinemas on October 23, 2026, just in time for Halloween, and Warner Bros. Is betting big on its quiet creep. No capes. No god-tier powers. Just Tom Rhys Harries as Matt Hagen, a former Hollywood star turned living clay after a brutal attack, and a descent into vengeance that’s less superhero saga, more slow-motion disintegration. It’s the kind of movie that doesn’t scream ‘blockbuster’, and that might be exactly why it could save DC. $40 million budget. $20–$29 million opening projected. That’s not a hit by Marvel standards. But in the current climate? It’s a win. Especially when you consider Supergirl flopped globally with $126 million against a $170 million spend, and even Superman (2025) only made $618 million. Less than Snyder’s 2013 version, adjusted for inflation. The new DCU has been stumbling since 2020. Thirteen films. A few hits. Most… forgettable. Or worse. Enter Clayface. Directed by James Watkins (Speak No Evil), it’s not a franchise starter. It’s not even a Batman movie, though Gotham City is there, in the background, through the lens of one of its most grotesque villains. Naomi Ackie, David Dencik, Max Minghella, and Eddie Marsan round out the cast. And yes, it’s set in James Gunn’s DC Universe. But no Batman. Not yet. The real story isn’t the plot. It’s the pivot. After years of billion-dollar gambles on gods and men, DC is trying something smaller, darker, cheaper. Like Joker in 2019. A $60 million film that became a global phenomenon, Clayface could be the blueprint. Genre movies. Lower stakes. Higher returns. If critics like it, if audiences feel the dread, if the overseas numbers hold. This could be the reset button. The question now isn’t whether Clayface will make money. It’s whether DC finally learns to stop chasing scale and start trusting tone. The answer comes this weekend.